Skip to main content

Gisela Teixido i Tura

-

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Doctor
Cardiology
General Hospital

Gisela Teixido i Tura

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Doctor
Cardiology
General Hospital

-

-

Projects

Diferencias de género y correlación genotipo-fenotipo en el pronóstico aórtico de pacientes con aortopatia familiar sindrómica. Análisis multicéntrico de la Red Española de Patología aórtica genética (REPAG)

IP: Gisela Teixido i Tura
Collaborators: Jose Fernando Rodríguez Palomares, Alicia Fresno González, Raul Aguilar Lopez, Lydia Dux-Santoy Hurtado
Funding agency: Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/FEC-INV-CLI 25/32 TEIXIDO
Duration: 01/11/2025 - 31/10/2026

Mapeo del crecimiento aórtico y refinamiento del genotipo para avanzar en la medicina de precisión en los síndromes de Marfan y Loeys-Dietz (AGM4Gen)

IP: Gisela Teixido i Tura
Collaborators: Juan Garrido Oliver, Ruperto Olivero Soldevila, Alicia Fresno González, Alberto Roque Pérez, Javier Limeres Freire
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 112500
Reference: PID2024-159353OB-I00
Duration: 01/09/2025 - 31/08/2028

Ministerio de Ciencia

Artificial intelligence for the quantitative assessment of aortic valve calcification on echocardiography images

IP: Andrea Guala
Collaborators: Ignacio Ferreira González, Pere López Gutierrez, Jose Fernando Rodríguez Palomares, Gisela Teixido i Tura, Juan Garrido Oliver, Lydia Dux-Santoy Hurtado, Laura Galián Gay
Funding agency: Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/GUALA/2024
Duration: 01/10/2024 - 31/12/2028

Impacto en la salud física, psicológica y cardiovascular de un programa de ejercicio de rehabilitación cardíaca en pacientes con síndrome de Marfan

IP: Gisela Teixido i Tura
Collaborators: -
Funding agency: Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC CLINICA 001
Duration: 01/01/2024 - 31/10/2024

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

Related professionals

Rosa Alcaraz Peñarrocha

Rosa Alcaraz Peñarrocha

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Andrea Muñoz Santisteban

Andrea Muñoz Santisteban

Multidisciplinary Nursing Research Group
Read more
Yuxin Ding

Yuxin Ding

Research technician
Biomedical Research in Melanoma
Read more
Mar Xunclà Lloret

Mar Xunclà Lloret

Predoctoral researcher
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.